Analysis of immunological and biochemical parameters after booster dose vaccination using protein-based and inactivated virus vaccine for safety
The Razi-CoV-Pars vaccine demonstrates a favorable safety profile and promising potential as an effective booster against current variants, particularly due to its significant protective titer against Omicron.
Authors
- Mojtaba Nofeli
- Esmat Malek (ORCID: https://orcid.org/0000-0002-8565-3582)
- Ladan Mokhberalsafa (ORCID: https://orcid.org/0000-0002-9437-4067)
- Monireh Hajimoradi (ORCID: https://orcid.org/0000-0002-0197-3993)
- Masoud Solaymani–Dodaran (ORCID: https://orcid.org/0000-0002-1817-5664)
- Seyad Hossein Razaz
- Seyed Reza Banihashemi
- Saeed Kalantari (ORCID: https://orcid.org/0000-0001-9896-4139)
- Ali Rezae Mokaram
- Mohammad Hossein Fallah Mehrabadi (ORCID: https://orcid.org/0000-0002-1221-7771)
- Ali Es‐haghi (ORCID: https://orcid.org/0000-0001-6533-3656)
- F. Sadeghi
Institutions
- Razi Vaccine and Serum Research Institute (IR)
- Iran University of Medical Sciences (IR)
- Rasool Akram Hospital (IR)
- Agricultural Research & Education Organization (IR)
Publication Details
- Journal
- Heliyon
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1016/j.heliyon.2024.e40124
- Citations
- 1
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- Razi Vaccine and Serum Research Institute